e-learning
resources
Vienna 2003
Tuesday 30.09.2003
The challenge of community acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cost-effectiveness of sequential iv-oral moxifloxacin versus current standard care in community acquired pneumonia to the Belgium health care system
K. Moeremans, L. Annemans (Brussels, Ghent, Belgium)
Source:
Annual Congress 2003 - The challenge of community acquired pneumonia
Session:
The challenge of community acquired pneumonia
Session type:
Poster Discussion
Number:
3406
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Moeremans, L. Annemans (Brussels, Ghent, Belgium). Cost-effectiveness of sequential iv-oral moxifloxacin versus current standard care in community acquired pneumonia to the Belgium health care system. Eur Respir J 2003; 22: Suppl. 45, 3406
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Effectiveness of TB diagnostics with microbiological methods in TB service and general health care institutions
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Implementing a community acquired pneumonia care bundle in the acute hospital setting
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Evaluation of a bespoke and innovative model of care to reduce emergency admissions for community acquired pneumonia.
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
An international perspective on the quality of care delivered to hospitalised patients with CAP
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
How does primary health care providers‘ pre-knowledge on tuberculosis affect the implementation of DOTS strategy in Serbia?
Source: Eur Respir J 2006; 28: Suppl. 50, 19s
Year: 2006
Patient and health care providers (HCP) perception of benefits and future use of acute non-invasive ventilation (NIV)
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Local antibiotic guidelines for management of adult community acquired pneumonia in UK hospitals
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Cost and effectiveness of integrated care intervention on the patients with COPD
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
A community tuberculosis (TB) management model: an academic centre/public health department partnership
Source: Eur Respir J 2003; 22: Suppl. 45, 42s
Year: 2003
Prescription of antibiotics for the treatment of community acquired pneumonia in a district general hospital in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
The impact of a domicilary COPD management care programme in the use of hospital resources
Source: Eur Respir J 2004; 24: Suppl. 48, 637s
Year: 2004
Improvement in community aquired pneumonia (CAP) management using a locally developed care bundle
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs
Source: Eur Respir J 2004; 23: 304-309
Year: 2004
Antibiotic use and misuse in the community: how to manage the problem
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017
The APO-audit in the primary health care of archangelsk region: the way to the effective therapy of community-acquired respiratory infections
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
Surge management in acute hospital care (how to escalate medical provision within hospitals during a pandemic)
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017
Tuberculosis control program in public health system (family health units) in São Luis-MA-Brazil: patients profiles and compliance
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006
Evaluation of therapy for nursing and health care-associated pneumonia(NHCAP) patients based on Japanese new guidelines.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept